Can quality-adjusted life year avoidance help in oncology drug reimbursement decisions?
Gespeichert in:
| Veröffentlicht in: | Journal of oncology practice 2008-01, Vol.4 (1), p.8-8 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 8 |
|---|---|
| container_issue | 1 |
| container_start_page | 8 |
| container_title | Journal of oncology practice |
| container_volume | 4 |
| creator | Calfee, John E |
| description | |
| doi_str_mv | 10.1200/JOP.0711501 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2793928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>755199081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-d2091ce1db48195e0091be865830145ec18ece27273132ff5f2b2c65282f09d13</originalsourceid><addsrcrecordid>eNpVUU1LxDAUDKL4ffIuuXmQaj6aTXJRZPETQQ-K3kKavK6RtlmTdmH_vRVX0dN7jzfMDDMIHVByQhkhp3cPjydEUioIXUPbVHNRlBP9uj7uQpSFLKXcQjs5vxNSCq0nm2iLESV0yeU2epnaDn8Mtgn9srD-fcg9eNyEGvASbMJ2EYO3nQP8Bs0chw7HzsUmzpbYp2GGE4S2GlKGFroee3Ahh9jl8z20Udsmw_5q7qLnq8un6U1x_3B9O724Lxznqi88I5o6oL4qFdUCyHhWoCZCcUJLAY4qcMAkk5xyVteiZhVzE8EUq4n2lO-is2_e-VC14N3oItnGzFNobVqaaIP5_-nCm5nFhWFSc83USHC0IkjxY4DcmzZkB01jO4hDNlIIqjVRX1LH30iXYs4J6l8VSsxXE2ZswqyaGNGHf439Yn-i55_NHYUp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755199081</pqid></control><display><type>article</type><title>Can quality-adjusted life year avoidance help in oncology drug reimbursement decisions?</title><source>American Society of Clinical Oncology Online Journals</source><source>Alma/SFX Local Collection</source><creator>Calfee, John E</creator><creatorcontrib>Calfee, John E</creatorcontrib><identifier>ISSN: 1554-7477</identifier><identifier>EISSN: 1935-469X</identifier><identifier>DOI: 10.1200/JOP.0711501</identifier><identifier>PMID: 20859437</identifier><language>eng</language><publisher>United States: American Society of Clinical Oncology</publisher><ispartof>Journal of oncology practice, 2008-01, Vol.4 (1), p.8-8</ispartof><rights>Copyright © 2008 by American Society of Clinical Oncology. 2008</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c338t-d2091ce1db48195e0091be865830145ec18ece27273132ff5f2b2c65282f09d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3729,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20859437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Calfee, John E</creatorcontrib><title>Can quality-adjusted life year avoidance help in oncology drug reimbursement decisions?</title><title>Journal of oncology practice</title><addtitle>J Oncol Pract</addtitle><issn>1554-7477</issn><issn>1935-469X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVUU1LxDAUDKL4ffIuuXmQaj6aTXJRZPETQQ-K3kKavK6RtlmTdmH_vRVX0dN7jzfMDDMIHVByQhkhp3cPjydEUioIXUPbVHNRlBP9uj7uQpSFLKXcQjs5vxNSCq0nm2iLESV0yeU2epnaDn8Mtgn9srD-fcg9eNyEGvASbMJ2EYO3nQP8Bs0chw7HzsUmzpbYp2GGE4S2GlKGFroee3Ahh9jl8z20Udsmw_5q7qLnq8un6U1x_3B9O724Lxznqi88I5o6oL4qFdUCyHhWoCZCcUJLAY4qcMAkk5xyVteiZhVzE8EUq4n2lO-is2_e-VC14N3oItnGzFNobVqaaIP5_-nCm5nFhWFSc83USHC0IkjxY4DcmzZkB01jO4hDNlIIqjVRX1LH30iXYs4J6l8VSsxXE2ZswqyaGNGHf439Yn-i55_NHYUp</recordid><startdate>200801</startdate><enddate>200801</enddate><creator>Calfee, John E</creator><general>American Society of Clinical Oncology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200801</creationdate><title>Can quality-adjusted life year avoidance help in oncology drug reimbursement decisions?</title><author>Calfee, John E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-d2091ce1db48195e0091be865830145ec18ece27273132ff5f2b2c65282f09d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Calfee, John E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of oncology practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Calfee, John E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can quality-adjusted life year avoidance help in oncology drug reimbursement decisions?</atitle><jtitle>Journal of oncology practice</jtitle><addtitle>J Oncol Pract</addtitle><date>2008-01</date><risdate>2008</risdate><volume>4</volume><issue>1</issue><spage>8</spage><epage>8</epage><pages>8-8</pages><issn>1554-7477</issn><eissn>1935-469X</eissn><cop>United States</cop><pub>American Society of Clinical Oncology</pub><pmid>20859437</pmid><doi>10.1200/JOP.0711501</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1554-7477 |
| ispartof | Journal of oncology practice, 2008-01, Vol.4 (1), p.8-8 |
| issn | 1554-7477 1935-469X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2793928 |
| source | American Society of Clinical Oncology Online Journals; Alma/SFX Local Collection |
| title | Can quality-adjusted life year avoidance help in oncology drug reimbursement decisions? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A00%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20quality-adjusted%20life%20year%20avoidance%20help%20in%20oncology%20drug%20reimbursement%20decisions?&rft.jtitle=Journal%20of%20oncology%20practice&rft.au=Calfee,%20John%20E&rft.date=2008-01&rft.volume=4&rft.issue=1&rft.spage=8&rft.epage=8&rft.pages=8-8&rft.issn=1554-7477&rft.eissn=1935-469X&rft_id=info:doi/10.1200/JOP.0711501&rft_dat=%3Cproquest_pubme%3E755199081%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=755199081&rft_id=info:pmid/20859437&rfr_iscdi=true |